JCS Analytics
JCS Analytics
  • Home
  • About
  • Privacy

Details
By J. Smith
J. Smith
Articles
May 12,2026
Last Updated: 17 May 2026
Hits: 94
  • Responsible AI
  • AI Strategy
  • AI Infrastructure
  • Sovereign AI
  • Data Governance

Sovereign AI Infrastructure and the New Shape of AI Strategy

Evan Solomon, minister of artificial intelligence and digital innovation, speaks at a press event on Monday. Courtesy of The Canadian Press.

Summary

AI strategy increasingly depends on more than models, applications, prompts, and productivity tools. Canada’s recent work with TELUS on sovereign AI infrastructure offers a useful example of how compute capacity, data residency, jurisdiction, energy use, cooling systems, and governance are becoming part of the AI readiness conversation. For data analytics professionals, the announcement highlights a broader shift: responsible AI adoption requires strong data foundations, reliable infrastructure, clear governance, and careful attention to sustainability and public accountability.

Key Points

  • Large-scale AI depends on physical and digital infrastructure, including compute capacity, networks, energy, cooling systems, and data governance.
  • Sovereign AI infrastructure can help organizations keep data, intellectual property, and sensitive workloads under domestic legal and regulatory frameworks.
  • AI readiness requires more than access to a model. Organizations also need reliable data pipelines, secure environments, and production-ready infrastructure.
  • Compute capacity is becoming a strategic issue because it affects who can participate in advanced AI development, including businesses, researchers, startups, and public institutions.

Read more: Sovereign AI Infrastructure and the New Shape of AI Strategy

Details
By J. Smith
J. Smith
Articles
May 7,2026
Last Updated: 07 May 2026
Hits: 131
  • Data Analytics
  • AI Governance
  • AI Adoption
  • Digital Strategy
  • Workforce Training

Lundbeck’s AI Days Show How Companies Can Make AI Adoption Practical

Lundbeck Headquarters, Valby, Denmark. Courtesy of H. Lundbeck A/S.

Abstract

Lundbeck’s AI Days offers a practical example of how organizations can approach AI adoption as a structured capability-building effort rather than a simple technology rollout. By connecting AI to business strategy, involving senior leadership, offering hands-on training, and emphasizing responsible use, Lundbeck shows how companies can help employees build confidence while aligning AI experimentation with clear organizational goals. For data and analytics teams, the example reinforces an important point: AI works best when it builds on strong data foundations, clear workflows, sound governance, and measurable business value.

Key Points

  • AI adoption should connect directly to business strategy, not sit apart as a disconnected technology initiative.
  • Leadership involvement helps set expectations and gives employees permission to learn, experiment, and rethink workflows.
  • Hands-on training matters more than hype because employees need practical examples tied to real work.
  • Governance should be built in from the start, including approved tools, data handling rules, human review, and validation standards.
  • Data and analytics teams play an important role because AI depends on clean data, clear processes, strong documentation, and measurable outcomes.

Read more: Lundbeck’s AI Days Show How Companies Can Make AI Adoption Practical

Details
By J. Smith
J. Smith
Articles
November 7,2025
Last Updated: 07 November 2025
Hits: 1303
  • AI in Drug Discovery
  • Federated Learning
  • Pharmaceutical Data
  • Biotech Innovation
  • Lilly TuneLab
  • NVIDIA

Eli Lilly’s AI Strategy: Opening High-Value Drug Discovery Models to the Biotech Ecosystem

AI Supercomputing

Lilly’s TuneLab platform and new AI supercomputing infrastructure enable biotech partners to accelerate drug discovery using secure, high-value machine learning models trained on decades of research data.

Abstract

Eli Lilly has introduced TuneLab, an AI platform that provides biotech companies access to drug discovery models trained on more than $1 billion of proprietary research data. The platform uses federated learning to let partners apply and improve these models without exchanging raw datasets. At the same time, Lilly is building one of the most powerful AI supercomputers in the pharmaceutical industry to support large-scale model development. Together, these moves represent a shift toward AI-augmented scientific workflows, where data, compute, and collaboration accelerate early-stage drug discovery.

Key Points

  • TuneLab provides access to high-value drug discovery models trained on decades of internal R&D data.
  • Federated learning protects proprietary data, allowing partners to use and strengthen models without sharing raw files.
  • A large-scale NVIDIA-powered supercomputer supports model training, simulation, and scientific AI agents.
  • The initiative lowers barriers for early-stage biotechs, offering capabilities that previously required significant infrastructure.
  • The broader shift is toward AI-augmented research, where discovery speed depends on both scientific insight and computational scale.

Read more: Eli Lilly’s AI Strategy: Opening High-Value Drug Discovery Models to the Biotech Ecosystem

Details
By J. Smith
J. Smith
Articles
September 14,2025
Last Updated: 14 September 2025
Hits: 427
  • Data Analytics
  • Healthcare Data
  • Personalized Medicine
  • Nordic Healthcare
  • Continuing Education

Bridging Data and Healthcare in the Nordics

Personalised Medicine from a Nordic Perspective

I completed Personalised Medicine from a Nordic Perspective through the University of Copenhagen and University of Iceland. The course explored how biobanks (collections of biological samples), health registries, and biomarkers (measurable health indicators) can be used to guide individual care, while also addressing risk communication, data protection, and broader ethical considerations.

For a data analyst, this provides valuable context for how health data is generated and applied, and shows the importance of collaboration between doctors and data scientists. The Nordic countries offer a strong case study: they maintain comprehensive health registries and biobanks, and are leaders in responsible data sharing across sectors. The material is presented in a way that makes these complex topics accessible to a broader audience, not just specialists.

This course was built and launched by two principal collaborators, Sisse Rye Ostrowski, MD, University of Copenhagen and Sædís Sævarsdóttir, MD, University of Iceland. They summed up its importance this way:

“The healthcare system is a wonderful place to be if you’re interested in data and developing algorithms. There are extremely complex data like omics data, register data, and data from wearables with all kinds of measurements you could possibly imagine. So, the healthcare field is the data playground of the future.” - Ostrowski

“We want people to understand the challenges involved and how collaboration and technological innovation is the key to shaping the future of healthcare.” - Sævarsdóttir

Explore the Course: Personalised Medicine from a Nordic Perspective

Details
By J. Smith
J. Smith
Articles
August 30,2025
Last Updated: 01 September 2025
Hits: 564
  • Python Programming
  • Tableau Visualizations
  • FDA Drug Shortages
  • SQLite Database
  • Healthcare Analytics

Streamlined Drug Shortage Tracking with Python and SQLite

Python and SQLite make drug shortage tracking reliable, efficient, and change-driven.

Abstract

Avoiding redundant outputs and focusing only on real changes makes drug shortage tracking both more efficient and more reliable. Python and SQLite work together to compare new data with existing records, ensuring updates occur only when needed and visualizations remain clear and accurate.

Key Points

  • Direct access to the FDA API reduces manual downloads and processing.
  • JSON normalization integrates smoothly with existing Python cleaning steps.
  • SQLite compares new data with stored records, updating only when changes occur.
  • Tableau visualizations use dynamic titles, color coding, and brand-specific calculations.
  • The approach avoids redundant file creation, ensuring efficient and reliable tracking.

Read more: Streamlined Drug Shortage Tracking with Python and SQLite

More Articles …

  1. Aligning CGM and BGM Readings Using Python and Tableau
  2. Adapting the 5K@ADA Race Results Project for 2025
  3. What's Your Hidden Superpower? Ask AI the Right Way.
  4. Why I Took Medical Courses to Strengthen My Data Skills
  • 1
  • 2
  • 3
  • 4

Page 1 of 4

Recent Activity

May 2026

  • Lundbeck’s AI Days Show How Companies Can Make AI Adoption Practical
  • Sovereign AI Infrastructure and the New Shape of AI Strategy

April 2026

  • Novo Nordisk Expands Its AI Strategy Through New OpenAI Partnership

Articles

  • 5K@EASD Race Results: Trends from 2023 and 2024
  • Adapting the 5K@ADA Race Results Project for 2025
  • Advanced Data Retrieval with Python
  • Aligning CGM and BGM Readings Using Python and Tableau
  • Analysis and Visualization of Public Health Agency of Canada COVID Cases
  • Bridging Data and Healthcare in the Nordics
  • Complex Web Scraping with Python
  • Creating a Calculated Field in Tableau to Get Get Data Aggregated by Month in the Correct Order
  • Data Analyst vs. Business Analyst: Similarities and Differences
  • Data Analytics for Type 2 Diabetes
  • Data Science and Responsible AI in the Pharmaceutical Industry: A Case Study of Novo Nordisk
  • Denmark's Leap into AI Innovation: A Model for Future Research and Development
  • Denmark’s Gefion AI Supercomputer Revolutionizes AI-driven Research
  • Eli Lilly’s AI Strategy: Opening High-Value Drug Discovery Models to the Biotech Ecosystem
  • Embracing AI: Balancing Augmentation, Ethics, and Environmental Impact
  • Enhancing Data Analysis and Visualization Workflows with AI
  • Exploring the 2023 5K@EASD Virtual Run: A Tableau Analysis
  • Exploring the Growth of GLP-1 RA Sales
  • How an Hour-by-Hour View Transforms Time in Range Insights
  • How Novo Nordisk is Utilizing AI for Drug Discovery

Top Subjects

  • Tableau
  • Python
  • Data Analytics
  • Novo Nordisk
  • Data Visualization
  • Tableau Visualizations
  • AI
  • 5K@EASD
  • Data Analysis
  • 5K@ADA
  • Type 2 Diabetes
  • Data Cleaning
  • Drug Discovery
  • AI Innovation
  • Quantum Computing
  • Diabetes Management
  • Race Results
  • Diabetes Awareness
  • Virtual 5K
  • Continuous Glucose Monitor
  • SQLite
  • SQLite Database Management
  • Continuous Glucose Monitoring
  • CGM Data Analysis
  • Artificial Intelligence
  • AI in Healthcare
  • Healthcare Data
  • AI in Drug Discovery
  • NVIDIA
  • Responsible AI

Contact Me

Search

End Diabetes Stigma

5K@ADA

5K@EASD

World Diabetes Day

Rochen Web Hosting

Bluesky Social

  • You are here:  
  • Home
  • About
  • Articles
 
Copyright © 2026 JCS Analytics. All Rights Reserved.
Joomla! is Free Software released under the GNU General Public License.